Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
Clinical trial NCT04334408 · WITHDRAWN
Trial details
- NCT number
- NCT04334408
- Sponsor
- Mayo Clinic
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2024-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.